Data / Drug companies / Nortriptyline hydrochloride
Nortriptyline hydrochloride: 29 companies and 82 products in the FDA NDC directory
Nortriptyline hydrochloride is listed in the FDA National Drug Code Directory by 29 companies, with 82 products in commercial distribution. 78 of the products (95.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; solution, and the newest product started marketing on September 25, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 29
- Products
- 82
- Generic (ANDA) products
- 78 (95.1%)
- Application numbers
- 7
- Routes
- Oral
- Brand names
- Pamelor
- openFDA record search
- api.fda.gov
Companies that list nortriptyline hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 9 | capsule | Generic drugs (ANDA) | November 17, 2023 |
| Remedyrepack Inc. | 6 | capsule | Generic drugs (ANDA) | September 25, 2026 |
| Proficient Rx LP | 5 | capsule | Generic drugs (ANDA) | May 8, 2000 |
| A-S Medication Solutions | 4 | capsule | Generic drugs (ANDA) | November 17, 2023 |
| Asclemed USA, Inc. | 4 | capsule | Generic drugs (ANDA) | November 17, 2023 |
| Coupler LLC | 4 | capsule | Generic drugs (ANDA) | March 3, 2026 |
| Dr. Reddy's Laboratories Inc. | 4 | capsule | Generic drugs (ANDA) | November 17, 2023 |
| SpecGx LLC | 4 | capsule | New drug applications (NDA) | August 1, 1977 |
| Sun Pharmaceutical Industries, Inc. | 4 | capsule | Generic drugs (ANDA) | May 8, 2000 |
| Teva Pharmaceuticals USA, Inc. | 4 | capsule | Generic drugs (ANDA) | April 6, 1995 |
| Zydus Lifesciences Limited | 4 | capsule | Generic drugs (ANDA) | February 10, 2022 |
| Zydus Pharmaceuticals USA Inc. | 4 | capsule | Generic drugs (ANDA) | February 10, 2022 |
| Direct RX | 3 | capsule | Generic drugs (ANDA) | September 15, 2021 |
| Advanced Rx of Tennessee, LLC | 2 | capsule | Generic drugs (ANDA) | June 3, 2025 |
| American Health Packaging | 2 | capsule | Generic drugs (ANDA) | December 9, 2025 |
| Bryant Ranch Prepack | 2 | capsule | Generic drugs (ANDA) | April 5, 1995 |
| Preferred Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | July 10, 2025 |
| Proficient Rx LP | 2 | capsule | Generic drugs (ANDA) | April 6, 1995 |
| Proficient Rx LP | 2 | capsule | Generic drugs (ANDA) | November 17, 2023 |
| St. Mary's Medical Park Pharmacy | 2 | capsule | Generic drugs (ANDA) | August 14, 2025 |
| Advagen Pharma Ltd | 1 | solution | Generic drugs (ANDA) | June 14, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | capsule | Generic drugs (ANDA) | April 6, 1995 |
| Mayne Pharma Inc. | 1 | capsule | Generic drugs (ANDA) | June 1, 2016 |
| Northwind Health Company, LLC | 1 | capsule | Generic drugs (ANDA) | October 31, 2023 |
| Northwind Health Company, LLC | 1 | capsule | Generic drugs (ANDA) | January 13, 2021 |
| NuCare Pharmaceuticals,Inc. | 1 | capsule | Generic drugs (ANDA) | May 8, 2000 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | June 1, 2016 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | November 17, 2023 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | solution | Generic drugs (ANDA) | August 23, 2000 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 80 | 97.6% |
| Solution | 2 | 2.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 78 | 95.1% |
| New drug applications (NDA) | 4 | 4.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Tricyclic Antidepressant | 82 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.